PRKN and cancer: Collectively, the distinct mitophagy mechanisms are differentially engaged in NDDs and cancers, with PINK1/Parkin signaling appearing to be more central to neurodegeneration, and receptor-mediated mitophagy pathways appearing to play a more prominent role in cancer.